March 28, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces two poster presentations at the European Society for ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

Gain Therapeutics' lead drug candidate, GT-02287, is in clinical development for the treatment of Parkinson's disease (PD) with or without a GBA1 mutation. The orally administered, brain-penetrant ...

The move follows the cancellation of roughly $400 million in funding for Columbia and the suspension of $175 million for the ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

Election sign orders are streaming in at TR Trades Reproduction, a family-owned printing business in Kitsilano. Their most recent run was 35 signs for a local Green candidate running in the ...

In contrast to an oral presentation, a “poster” is a visual ... one available from WebAIM or use one of the pre-designed templates available from Boise State. When you finish designing your poster, ...

New tremors rattled survivors of Friday’s earthquake, which killed more than 1,600 people, while the government continued its bombing campaign elsewhere in the country. By Sui-Lee Wee ...

Want to know more about these projects, find them here in the abstract book. It has been an interesting day and we hope all attendees gained knowledge and shared their perspectives on Educational ...